Arrowpoint Investment Partners »

Madrigal Pharmaceuticals shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $363k 792 458.66

More positions owned by Arrowpoint Investment Partners

Aegon Amer Reg 1 Cert (AEG)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Select Sector Spdr Tr Sbi Healthcare Call Option (XLV)
Hallador Energy (HNRG)
Echostar Corp Cl A (SATS)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Astera Labs (ALAB)
Atour Lifestyle Hldgs Sponsored Ads (ATAT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Bristol Myers Squibb Call Option (BMY)
Merck & Co Call Option (MRK)
Pfizer Call Option (PFE)
Abbvie Call Option (ABBV)
Hesai Group Sponsored Ads (HSAI)
Comfort Systems USA (FIX)

View all positions for Arrowpoint Investment Partners

Top funds holding Madrigal Pharmaceuticals

Baker Bros. Advisors
Rtw Investments
Paulson & Co
Henderson Group
venBio Select Advisor
Vanguard Group
BlackRock
State Street Corporation
Geode Capital Management
William Blair Investment Management
Wellington Management Company
FMR
Goldman Sachs Group
Susquehanna International
Invesco

View all funds holding Madrigal Pharmaceuticals